Title
Comparison of the Effectiveness of the Ultrasound Guided Injections in Patients With Shoulder Impingement Syndrome
Comparison of the Effectiveness of the Ultrasound Guided Subacromial, Acromioclavicular With Subacromial Injection and Suprascapular Nerve Block in Patients With Shoulder Impingement Syndrome ; A Randomized Controlled, Single Blind, Clinical Trial
Phase
Phase 4Lead Sponsor
Bursa Yüksek İhtisas Education and Research HospitalStudy Type
InterventionalStatus
Completed No Results PostedIndication/Condition
Shoulder Impingement Ultrasound Guided InjectionIntervention/Treatment
bupivacaine and methylprednisolone [bupivacaine (73880), methylprednisolone (2949)] bupivacaine and methylprednisolone [bupivacaine (73880), methylprednisolone (2949)] bupivacaine and methylprednisolone [bupivacaine (73880), methylprednisolone (2949)]Study Participants
88Shoulder pain, which is the third most common cause of musculoskeletal pain, has different etiologies. Muscle, bone structures and connective tissue pathologies can cause shoulder pain. Impingement syndrome (IS), which can cover many terms such as rotator cuff disorders, tendinitis and tears, is one of the most common pathologies of shoulder pain.
The hypothesis of this study was that injection types including ACJ would increase treatment efficacy.Therefore, this study investigated the six-month follow-up results of patients undergoing SA injection and SSNB and those receiving SA and ACJ injection.
5 mL of 0.25% bupivacaine containing 20 mg methylprednisolone was administered to the subacromial area
5 mL of 0.25% bupivacaine containing 20 mg methylprednisolone was administered to the subacromial area for the subacromial+acromioclavicular joint injection. In addition, 2 mL of 20 mg methylprednisolone and the same concentration of local anaesthetic were injected into the acromioclavicular joint
suprascapular nerve block was administered with a mixture of 10 mL of 0.25% bupivacaine and 40 mg methylprednisolone
ultrasound (US)-guided subacromial injection
ultrasound (US)-guided acromioclavicular joint and subacromial injection
ultrasound (US)-guided suprascapular nerve block
Inclusion Criteria: patients aged 18-65, who were suffering from shoulder pain for more than three months and who were diagnosed with IS. All patients included in the study were diagnosed with IS using Shoulder Magnetic Resonance imaging. Exclusion Criteria: the presence of cervical radiculopathy; undergoing shoulder operation before; the presence of central nervous system or the presence of rheumatological disease, and polyneuropathy; receiving physical therapy in the shoulder area with a diagnosis of IS within the last six months; and receiving any injection therapy in the past.
